Two new appointments at Biovail
This article was originally published in Scrip
Biovail (Canada) has appointed Peggy Mulligan chief financial officer and Dr Neil Sussman vice-president of neurologic and psychiatric development at Biovail Technologies. Mrs Mulligan succeeds Adrian De Saldanha, who had been serving as Biovail's interim chief financial officer; she most recently served as a principal at Priiva Consulting. Dr Sussman was previously president of NMSNeuro Consulting, specialising in therapeutic areas such as dementia, mania, neuroprotection, multiple sclerosis and Parkinson's disease. Before that, he was senior director of CNS clinical research at Kyowa Pharmaceutical.